
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Oncology Today with Dr Neil Love
00:00
ctDNA for Upper Tract and Adjuvant Choices
Matthew Galsky and panel discuss subgroup limits, POUT chemotherapy data, and adjuvant options for upper tract disease.
Play episode from 46:51
Transcript


